Relationship between blood levels of heavy metals and Parkinson's disease in China

Neuroepidemiology

Volumn 34, Issue 1, 2010, Pages 18-24

  Fukushima, Tetsuhito ^a   Tan, Xiaodong ^b   Luo, Yunwen ^c   Kanda, Hideyuki ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b WUHAN UNIVERSITY   (China)

^c Xiangfan No 1 Hospital   (China)

Author keywords

Blood heavy metals; Case control study; China; General population; Manganese poisoning; Nutritional survey; Parkinson's disease

Indexed keywords

HEAVY METAL; IRON; MANGANESE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; EATING HABIT; FEMALE; HUMAN; IDIOPATHIC DISEASE; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUTRITION; PARKINSON DISEASE; POPULATION; RISK FACTOR;

CHINA; DIET; FEMALE; HUMANS; IRON; MALE; MANGANESE; METALS, HEAVY; MIDDLE AGED; PARKINSON DISEASE; PHOTOPERIOD; RURAL POPULATION; SOCIOECONOMIC FACTORS; TIME FACTORS; URBAN POPULATION;

EID: 70350671252     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000255462     Document Type: Article

References (42)

1. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW: Parkinson disease in twins: an etiologic study. JAMA 1999; 281: 341-346. (Pubitemid 29061038)
2. Piccinin GL, Piccirilli M, Finali G, Stefano E: MPTP: a new chapter in the history of Parkinson's disease. Riv Neurol 1989; 59: 103-107.
3. Fall PA, Fredrikson M, Axelson O, Granerus AK: Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 1999; 14: 28-37.
4. Hellenbrand W, Boeing H, Robra BP, Seidler A, Vieregge P, Nischan P, Joerg J, Oertel WH, Schneider E, Ulm G: Diet and Parkinson's disease. II. A possible role for the past intake of specific nutrients: results from a self-administered food-frequency questionnaire in a case-control study. Neurology 1996; 47: 644-650.
5. Johnson CC, Gorell JM, Rybicki BA, Sanders K, Peterson EL: Adult nutrient intake as a risk factor for Parkinson's disease. Int J Epidemiol 1999; 28: 1102-1109.
6. Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR: Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000; 283: 2674-2679.
7. Tanner CM: The role of environmental toxines in the etiology of Parkinson's disease. Trends Neurosci 1989; 12: 49-54.
8. Gershanik OS, Luquin MR, Scipioni O, Obeso JA: Isoniazid therapy in Parkinson's disease. Mov Disord 1988; 3: 133-139.
9. Fujii C, Harada S, Ohkoshi N, Hayashi A, Yoshizawa K: Study on Parkinson's disease and alcohol drinking. Nihon Arukoru Yakubutsu Igakkai Zasshi 1998; 33: 683-691.
10. Langston JW, Ballard P, Tetrud JW, Irwin I: Chronic Parkinsonism in humans due to a product of meperidine analog synthesis. Science 1983; 219: 979-980.
11. Gearhart DA, Neafsey EJ, Collins MA: Characterization of brain - -carboline-2-N-methyltransferase, an enzyme that may play a role in idiopathic Parkinson's disease. Neurochem Res 1997; 22: 113-121.
12. Kotake Y: Tetrahydroisoquinoline derivatives as possible Parkinson's disease-inducing substances. Yakugaku Zasshi 2002; 122: 975-982.
13. Mizuno Y, Sone N, Saitoh T: Effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. J Neurochem 1987; 48: 1787-1793.
14. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y: Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989; 163: 1450-1455.
15. Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD: Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990; 55: 2142-2145.
16. Williams AC, Pall HS, Steventon GB, Green S, Buttrum S, Molloy H, Waring RH: Nmethylation of pyridines and Parkinson's disease. Adv Neurol 1993; 60: 194-196.
17. Parsons RB, Smith ML, Williams AC, Waring RH, Ramsden DB: Expression of nicotinamide N-methyltransferase (E.C.2.1.1.1) in the Parkinsonian brain. J Neuropathol Exp Neurol 2002; 61: 111-124.
18. Fukushima T, Tawara T, Isobe A, Hojo N, Shiwaku K, Yamane Y: Radical formation site of cerebral complex I and Parkinson's disease. J Neurosci Res 1995; 42: 385-390.
19. Fukushima T, Kaetsu A, Lim H, Moriyama M: Possible role of 1-methylnicotinamide in the pathogenesis of Parkinson's disease. Exp Toxicol Pathol 2002; 53: 469-473.
20. Couper J: On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharm 1837; 1: 41-42.
21. Takeda A: Manganese action in brain function. Brain Res Brain Res Rev 2003; 41: 79-87.
22. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ: Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997; 48: 650-658.
23. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H: Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 2003; 60: 1761-1766.
24. Sugawara A, Yokoyama H, Ohta M, Maeda T, Tanaka K, Fukushima T: The effect of heavy metals on nicotinamide N-methyltransferase activity in vitro relating to Parkinson's disease. Environ Health Prev Med 2005; 10: 180-183.
25. Daniel SE, Lees AJ: Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993; 39: 165-172.
26. Qu F, Yang X: Nutritional and Health Survey for Chinese Citizens in 2002. Beijing, People's Health Press, 2006.
27. Kaji H, Ohsaki Y, Rokujo C, Higashi T, Fujino A, Kamada T: Determination of blood and urine manganese (Mn) concentrations and the application of static sensography as the indices of Mn-exposure among Mn-refinery workers. J UOEH 1993; 15: 287-1196
28. Bowler RM, Roels HA, Nakagawa S, Drezgic M, Diamond E, Park R, Koller W, Bowler RP, Mergler D, Bouchard M, Smith D, Gwiazda R, Doty RL: Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med 2007; 64: 167-177.
29. Lucchini R, Apostoli P, Perrone C, Placidi D, Albini E, Migliorati P, Mergler D, Sassine MP, Palmi S, Alessio L: Long-term exposure to 'low levels' of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology 1999; 20: 287-1197
30. Ai LB, Chua LH, New AL, Lee BL, Liu YM, Chia SE, Ong CN: Urinary homovanillic acid (HVA) and vanillymandelic acid (VMA) in workers exposed to manganese dust. Biol Trace Elem Res 1998; 64: 89-99.
31. Jiménez-Jiménez FJ, Molina JA, Aguilar MV, Aguilar MV, Arrieta FJ, Jorge-Santamaría A, Cabrera-Valdivia F, Ayuso-Peralta L, Rabasa M, Vázquez A, García-Albea E, Martínez- Para MC: Serum and urinary manganese levels in patients with Parkinson's disease. Acta Neurol Scand 1995; 91: 317-320.
32. Chen WH, Shih PY: The serum ferrokinetics in Parkinson's disease. Gaoxiong Yi Xue Ke Xue Za Zhi 1992; 8: 581-584.
33. Gellein K, Syversen T, Steinnes E, Nilsen TI, Dahl OP, Mitrovic S, Duraj D, Flaten TP: Trace elements in serum from patients with Parkinson's disease - a prospective casecontrol study: The Nord-Trøndelag Health Study (HUNT). Brain Res 2008; 1219: 111-115.
34. Dressler J, Schulz K, Klemm M, Schüttig R, Beuthin A, Felscher D: Lethal manganesecadmium intoxication: a case report. Arch Toxicol 2002; 76: 449-451.
35. Katsuragi T, Takahashi T, Shibuya K, Nagatomo H, Iwabuchi K: A patient with parkinsonism presenting hyperintensity in the globus pallidus on T 1 -weighted MR images: the correlation with manganese poisoning. Rinsho Shinkeigaku 1996; 36: 780-782.
36. Hudnell HK: Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies. Neurotoxicology 1999; 20: 379-397.
37. Agha F, Sadaruddin A, Khatoon N: Effect of environmental lead pollution on blood lead levels in traffic police constables in Islamabad, Pakistan. J Pak Med Assoc 2005; 55: 410-413.
38. Baldwin M, Mergler D, Larribe F, Bélanger S, Tardif R, Bilodeau L, Hudnell K: Bioindicator and exposure data for a population-based study of manganese. Neurotoxicology 1999; 20: 343-354.
39. Bouchard M, Laforest F, Vandelac L, Bellinger D, Mergler D: Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water. Environ Health Perspect 2007; 115: 122-127.
40. Rodríguez-Agudelo Y, Riojas-Rodríguez H, Ríos C, Rosas I, Sabido Pedraza E, Miranda J, Siebe C, Texcalac JL, Santos-Burgoa C: Motor alterations associated with exposure to manganese in the environment in Mexico. Sci Total Environ 2006; 368: 542-556.
41. Baldwin M, Bouchard M, Larribe F, Mergler D: Past occupational exposure to airborne manganese in a manganese alloy plant. J Occup Environ Hyg 2008; 5: 426-437.
42. Takser L, Lafond J, Bouchard M, St-Amour G, Mergler D: Manganese levels during pregnancy and at birth: relation to environmental factors and smoking in a Southwest Quebec population. Environ Res 2004; 95: 119-125.